P1.08D.01 The Efficacy of Durvalumab after Concurrent Chemoradiotherapy for EGFR-Mutated Stage III Non-Small Cell Lung Cancer (NEJ063).

Autor: Kida, G., Fujisaki, T., Miyauchi, E., Kikuchi, H., Hommura, F., Yokoo, K., Tanaka, H., Kikuchi, T., Jingu, D., Sugisaka, J., Watanabe, K., Yoshimura, N., Nakagawa, T., Nogawa, H., Sato, M., Nakazawa, K., Soda, S., Takigami, A., Arai, D., Masubuchi, K.
Zdroj: Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS182-S183, 2p
Databáze: Complementary Index